The role of Foxp3 and Tbet co-expressing Treg cells in lung carcinoma

References

• van Klaveren R. J. Lung cancer screening with low dose computed tomography: where do we stand today? Eur J Cancer. 2009;45(Suppl 1):375–6. doi:10.1016/S0959-8049(09)70054-1. PMID:19775636
   PubMedGoogle Scholar
• Rogers T. K., Hamilton W., Tod A., Neal R. Response to: What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK? Thorax. 2015;70:184. doi:10.1136/thoraxjnl-2014-206514. PMID:25535292
   PubMed Web of Science ®Google Scholar
• Reppert S. Boross I, Koslowski M, Türeci Ö, Koch S, Lehr HA, Finotto S. A role for T-bet-mediated tumour immune surveillance in anti-IL-17 ;A treatment of lung cancer. Nature communications. 2011;2:600. doi:10.1038/ncomms1609. PMID:22186896
   PubMed Web of Science ®Google Scholar
• Werneck M. B., Lugo-Villarino G., Hwang E. S., Cantor H., Glimcher L. H. T-bet plays a key role in NK-mediated control of melanoma metastatic disease. Journal of immunology. 2008;180:8004–10. doi:10.4049/jimmunol.180.12.8004.
   PubMed Web of Science ®Google Scholar
• Cruz-Guilloty F, Pipkin ME, Djuretic IM, Levanon D, Lotem J, Lichtenheld MG, Groner Y, Rao A. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. The Journal of experimental medicine. 2009;206:51–59. doi:10.1084/jem.20081242. PMID:19139168
   PubMed Web of Science ®Google Scholar
• Lazarevic V., Glimcher L. H. T-bet in disease. Nat Immunol. 2011;12:597–606. doi:10.1038/ni.2059. PMID:21685955
   PubMed Web of Science ®Google Scholar
• Szabo S. J. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100:655–69. doi:10.1016/S0092-8674(00)80702-3. PMID:10761931
   PubMed Web of Science ®Google Scholar
• Townsend M. J, Weinmann AS, Matsuda JL, Salomon R, Farnham PJ, Biron CA, Gapin L, Glimcher LH. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity. 2004;20:477–94. doi:10.1016/S1074-7613(04)00076-7. PMID:15084276
   PubMed Web of Science ®Google Scholar
• Andreev K. Impaired T-bet-pSTAT1alpha and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma. British journal of cancer. 2015:113:902–13. doi:10.1038/bjc.2015.255. PMID:26348446
   PubMed Web of Science ®Google Scholar
• Perales M. A, Blachere NE, Engelhorn ME, Ferrone CR, Gold JS, Gregor PD, Noffz G, Wolchok JD, Houghton AN. Strategies to overcome immune ignorance and tolerance. Seminars in Cancer Biology. 2002;12:63–71. doi:10.1006/scbi.2001.0397. PMID:11926414
   PubMed Web of Science ®Google Scholar
• Motz G. T., Coukos G. Deciphering and Reversing Tumor Immune Suppression. Immunity. 2013;39:61–73. doi:10.1016/j.immuni.2013.07.005. PMID:23890064
   PubMed Web of Science ®Google Scholar
• Curiel T. J, Coukos G., Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature medicine. 2004;10:942–9. doi:10.1038/nm1093. PMID:15322536
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Regulatory T cells in the past and for the future. European journal of immunology. 2008;38:901–3. doi:10.1002/eji.200890012. PMID:18395855
   PubMed Web of Science ®Google Scholar
• Berendt M. J., North R. J. T-Cell-Mediated Suppression of Anti-Tumor Immunity – Explanation for Progressive Growth of an Immunogenic Tumor. Journal of Experimental Medicine. 1980;151:69–80. doi:10.1084/jem.151.1.69. PMID:6444236
   PubMed Web of Science ®Google Scholar
• Byrne W. L., Mills K. H. G., Lederer J. A, O'Sullivan G. C. Targeting Regulatory T Cells in Cancer. Cancer research. 2011;71:6915–20. doi:10.1158/0008-5472.CAN-11-1156. PMID:22068034
   PubMed Web of Science ®Google Scholar
• Woo E. Y, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer research. 2001;61:4766–72. PMID:11406550
   PubMed Web of Science ®Google Scholar
• Li H, Zhao H, Yu J, Su Y, Cao S, An X, Ren X. Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietin. Cancer Immunology Immunotherapy. 2011;60:1587–96. doi:10.1007/s00262-011-1059-6. PMID:21681373
   PubMed Web of Science ®Google Scholar
• Shimizu K, Nakata M, Hirami Y, Yukawa T, Maeda A, Tanemoto K. Tumor-Infiltrating Foxp3+Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 2010;5:585–90. doi:10.1097/JTO.0b013e3181d60fd7. PMID:20234320
   PubMed Web of Science ®Google Scholar
• Khattri R., Cox T., Yasayko S. A, Ramsdell F. An essential role for Scurfin in CD4(+)CD25(+) T regulatory cells. Nature Immunology. 2003;4:337–42. doi:10.1038/ni909. PMID:12612581
   PubMed Web of Science ®Google Scholar
• Fontenot J. D., Gavin M. A, Rudensky A. Y. Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells. Nature Immunology. 2003;4:330–6. doi:10.1038/ni904. PMID:12612578
   PubMed Web of Science ®Google Scholar
• Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61. doi:10.1126/science.1079490. PMID:12522256
   PubMed Web of Science ®Google Scholar
• Koch M. A, Thomas KR, Perdue NR, Smigiel KS, Srivastava S, Campbell DJ. T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor beta2. Immunity. 2012;37:501–10. doi:10.1016/j.immuni.2012.05.031. PMID:22960221
   PubMed Web of Science ®Google Scholar
• Koch M. A, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol. 2009;10:595–602. doi:10.1038/ni.1731. PMID:19412181
   PubMed Web of Science ®Google Scholar
• Yu F., Sharma S., Edwards J., Feigenbaum L., Zhu J. Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance. Nat Immunol. 2015;16:197–206. doi:10.1038/ni.3053. PMID:25501630
   PubMed Web of Science ®Google Scholar
• Zhou L., Chong M. M., Littman D. R. Plasticity of CD4+ T cell lineage differentiation. Immunity. 2009;30:646–55. doi:10.1016/j.immuni.2009.05.001. PMID:19464987
   PubMed Web of Science ®Google Scholar
• Andreev K., Graser A., Maier A., Mousset S., Finotto S. Therapeutical measures to control airway tolerance in asthma and lung cancer. Frontiers in immunology. 2012;3:216. doi:10.3389/fimmu.2012.00216. PMID:22855687
   PubMed Web of Science ®Google Scholar
• Fischer J. R, Darjes H, Lahm H, Schindel M, Drings P, Krammer PH. Constitutive secretion of bioactive transforming growth factor beta 1 by small cell lung cancer cell lines. Eur J Cancer. 1994;30A:2125–9. doi:10.1016/0959-8049(94)00364-B.
   PubMed Web of Science ®Google Scholar
• Sargent E. R, Gomella LG, Wade TP, Ewing MW, Kasid A, Linehan WM. Expression of mRNA for transforming growth factors-alpha and -beta and secretion of transforming growth factor-beta by renal cell carcinoma cell lines. Cancer Commun. 1989;1:317–22. doi:10.3727/095535489820874904. PMID:2488683
   PubMedGoogle Scholar
• Chen W Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. The Journal of experimental medicine. 2003;198:1875–86. doi:10.1084/jem.20030152. PMID:14676299
   PubMed Web of Science ®Google Scholar
• Fantini M, C Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. Journal of immunology. 2004;172:5149–53. doi:10.4049/jimmunol.172.9.5149.
   PubMed Web of Science ®Google Scholar
• Lazarevic V., Glimcher L. H., Lord G. M. T-bet: A bridge between innate and adaptive immunity. Nature Reviews Immunology. 2013;13:777–89. doi:10.1038/nri3536. PMID:24113868
   PubMed Web of Science ®Google Scholar
• Hall A. O, Beiting DP, Tato C, John B, Oldenhove G, Lombana CG, Pritchard GH, Silver JS, Bouladoux N, Stumhofer JS, et al. The Cytokines Interleukin 27 and Interferon-gamma Promote Distinct Treg Cell Populations Required to Limit Infection-Induced Pathology. Immunity. 2012;37:511–23. doi:10.1016/j.immuni.2012.06.014. PMID:22981537
   PubMed Web of Science ®Google Scholar
• Finotto S, Hausding M, Doganci A, Maxeiner JH, Lehr HA, Luft C, Galle PR, Glimcher LH. Asthmatic changes in mice lacking T-bet are mediated by IL-13. International immunology. 2005;17:993–1007. doi:10.1093/intimm/dxh281. PMID:16000330
   PubMed Web of Science ®Google Scholar
• Neurath M. F, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H, Mizoguchi A, Mizoguchi E, Mudter J, Galle PR. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. The Journal of experimental medicine. 2002;195:1129–43. doi:10.1084/jem.20011956. PMID:11994418
   PubMed Web of Science ®Google Scholar
• Kachler K, Bailer M., Heim L, Schumacher F, Reichel M, Holzinger CD, Trump S, Mittler S, Monti J, Trufa DI, et al. Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in Non-Small Cell Lung Carcinoma. Cancer Res. 2017;77(21):5963–5976. doi:10.1158/0008-5472.CAN-16-3313. PMID:28883000
   PubMedGoogle Scholar
• Vahl J. M, Friedrich J, Mittler S, Trump S, Heim L, Kachler K, Balabko L, Fuhrich N, Geppert CI, Trufa DI, et al. Interleukin-10-regulated tumour tolerance in non-small cell lung cancer. British journal of cancer. 2017;117(11):1644–1655. doi:10.1038/bjc.2017.336. PMID:29016555
   PubMed Web of Science ®Google Scholar
• Lazarevic V, Chen X, Shim JH, Hwang ES, Jang E, Bolm AN, Oukka M, Kuchroo VK, Glimcher LH. T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat. Nat Immunol. 2011;12:96–104. doi:10.1038/ni.1969. PMID:21151104
   PubMed Web of Science ®Google Scholar
• Zhang F., Meng G., Strober W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol. 2008;9:1297–306. doi:10.1038/ni.1663. PMID:18849990
   PubMed Web of Science ®Google Scholar
• Zheng W., Flavell R. A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 ;T cells. Cell. 1997;89:587–96. doi:10.1016/S0092-8674(00)80240-8. PMID:9160750
   PubMed Web of Science ®Google Scholar
• Zhu J, Jankovic D, Oler AJ, Wei G, Sharma S, Hu G, Guo L, Yagi R, Yamane H, Punkosdy G. The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity. 2012;37:660–73. doi:10.1016/j.immuni.2012.09.007. PMID:23041064
   PubMed Web of Science ®Google Scholar
• Geissmann F, Revy P, Regnault A, Lepelletier Y, Dy M, Brousse N, Amigorena S, Hermine O, Durandy A. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. Journal of immunology. 1999;162:4567–75.
   PubMed Web of Science ®Google Scholar
• Siegel P. M., Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nature Reviews Cancer. 2003;3:807–20. doi:10.1038/nrc1208. PMID:14557817
   PubMed Web of Science ®Google Scholar
• Massague J. TGF beta in cancer. Cell. 2008;134:215–30. doi:10.1016/j.cell.2008.07.001. PMID:18662538
   PubMed Web of Science ®Google Scholar
• Thomas D. A., Massague J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune sur-veillance. Cancer cell. 2005;8:369–80. doi:10.1016/j.ccr.2005.10.012. PMID:16286245
   PubMed Web of Science ®Google Scholar
• Eisenhut F Heim L, Trump S, Mittler S, Sopel N, Andreev K, Ferrazzi F, Ekici AB, Rieker R, Springel R, et al. FAM13 A is associated with non-small cell lung cancer (NSCLC) progression and controls tumor cell proliferation and survival. Oncoimmunology. 2017;6:e1256526. doi:10.1080/2162402X.2016.1256526. PMID:28197372
   PubMed Web of Science ®Google Scholar
• Balabko L, Andreev K, Burmann N, Schubert M, Mathews M, Trufa DI, Reppert S, Rau T, Schicht M, Sirbu H, et al. Increased expression of the Th17-IL-6R/pSTAT3/BATF/RorgammaT-axis in the tumoural region of adenocarcinoma as compared to squamous cell carcinoma of the lung. Scientific reports. 2014;4:7396. doi:10.1038/srep07396. PMID:25491772
   PubMed Web of Science ®Google Scholar
• Schramm C, Protschka M, Köhler HH, Podlech J, Reddehase MJ, Schirmacher P, Galle PR, Lohse AW, Blessing M. Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice. Am J Physiol Gastrointest Liver Physiol. 2003;284:G525–535. doi:10.1152/ajpgi.00286.2002. PMID:12466145
   PubMed Web of Science ®Google Scholar
• Sauer K. A., Scholtes P., Karwot R., Finotto S. Isolation of CD4+ T cells from murine lungs: a method to analyze ongoing immune responses in the lung. Nature protocols. 2006;1:2870–5. doi:10.1038/nprot.2006.435. PMID:17406546
   PubMed Web of Science ®Google Scholar
• Doganci A, Eigenbrod T, Krug N, De Sanctis GT, Hausding M, Erpenbeck VJ, Haddad el-B, Lehr HA, Schmitt E, Bopp T, et al. The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. The Journal of clinical investigation. 2005;115:313–25. doi:10.1172/JCI200522433. PMID:15668741
   PubMed Web of Science ®Google Scholar